Physician-level variation in axillary surgery in older adults with T1N0 hormone receptor-positive breast cancer: A retrospective population-based cohort study

被引:0
|
作者
Minami, Christina A. [1 ,2 ,3 ,4 ,7 ]
Jin, Ginger [4 ]
Freedman, Rachel A. [2 ,3 ,4 ,5 ]
Schonberg, Mara A. [3 ,6 ]
King, Tari A. [1 ,2 ,3 ]
Mittendorf, Elizabeth A. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Dept Surg, Div Breast Surg, Boston, MA 02115 USA
[2] Dana Farber Brigham Canc Ctr, Breast Oncol Program, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA USA
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[6] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA
[7] 450 Brookline Ave,Yawkey 1274, Boston, MA 02215 USA
关键词
Breast cancer; Geriatric oncology; Frailty; Life expectancy; Locoregional therapy; Surgery; PATIENT GENDER; DISSECTION; OUTCOMES; QUALITY; CARE;
D O I
10.1016/j.jgo.2024.101795
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: We sought to determine how considerations specific to older adults impact between- and within-surgeon variation in axillary surgery use in women >= 70 years with T1N0 HR+ breast cancer. Materials and Methods: Females >= 70 years with T1N0 HR+/HER2-negative breast cancer diagnosed from 2013 to 2015 in SEER-Medicare were identified and linked to the American Medical Association Masterfile. The outcome of interest was axillary surgery. Key patient-level variables included the Charlson Comorbidity Index (CCI) score, frailty (based on a claims-based frailty index score), and age (>= 75 vs <75). Multilevel mixed models with surgeon clusters were used to estimate the intracluster correlation coefficient (ICC) (between-surgeon variance), with 1-ICC representing within-surgeon variance. Results: Of the 4410 participants included, 6.1% had a CCI score of >= 3, 20.7% were frail, and 58.3% were >= 75 years; 86.1% underwent axillary surgery. No surgeon omitted axillary surgery in all patients, but 42.3% of surgeons performed axillary surgery in all patients. In the null model, 10.5% of the variance in the axillary evaluation was attributable to between-surgeon differences. After adjusting for CCI score, frailty, and age in mixed models, between-surgeon variance increased to 13.0%. Discussion: In this population, axillary surgery varies more within surgeons than between surgeons, suggesting that surgeons are not taking an "all-or-nothing" approach. Comorbidities, frailty, and age accounted for a small proportion of the variation, suggesting nuanced decision-making may include additional, unmeasured factors such as differences in surgeon-patient communication.
引用
收藏
页数:7
相关论文
共 43 条
  • [1] Physician-level variation in axillary surgery in older adults with T1NO hormone receptor-positive breast cancer
    Minami, Christina Ahn
    Jin, Ginger
    Freedman, Rachel A.
    Schonberg, Mara A.
    King, Tari A.
    Mittendorf, Elizabeth A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 284 - 284
  • [2] Locoregional therapy trends by frailty and life expectancy in older adults with T1N0 hormone receptor-positive breast cancer.
    Minami, Christina Ahn
    Jin, Ginger
    Freedman, Rachel A.
    Schonberg, Mara A.
    King, Tari A.
    Mittendorf, Elizabeth A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Are single hormone receptor-positive phenotypes biologically and clinically distinct breast cancer? A population-based study
    Li, Y.
    Wu, Y.
    Yang, D.
    Li, H.
    Ren, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [4] Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark
    Christiansen, Peer
    Bjerre, Karsten
    Ejlertsen, Bent
    Jensen, Maj-Britt
    Rasmussen, Birgitte B.
    Laenkholm, Anne-Vibeke
    Kroman, Niels
    Ewertz, Marianne
    Offersen, Birgitte
    Toftdahl, Dorte B.
    Moller, Susanne
    Mouridsen, Henning T.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (18) : 1363 - 1372
  • [5] Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
    Schroeder, Brock
    Zhang, Yi
    Stal, Olle
    Fornander, Tommy
    Brufsky, Adam
    Sgroi, Dennis C.
    Schnabel, Catherine A.
    [J]. NPJ BREAST CANCER, 2017, 3
  • [6] Race, RNA-based recurrence scores, and survival of early hormone receptor-positive breast cancer: A population-based study
    Han, Yunan
    Colditz, Graham A.
    Liu, Ying
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [7] Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
    Brock Schroeder
    Yi Zhang
    Olle Stål
    Tommy Fornander
    Adam Brufsky
    Dennis C. Sgroi
    Catherine A. Schnabel
    [J]. npj Breast Cancer, 3
  • [8] End-of-life endocrine treatment of older hormone receptor-positive metastatic breast cancer patients: A nationwide Swedish retrospective cohort study
    Szilcz, Mate
    Wastesson, Jonas
    Lindman, Henrik
    Johnell, Kristina
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 111 - 111
  • [9] Clinical Features and Survival of Single Hormone Receptor-Positive Breast Cancer: A Population-Based Study of 531,605 Patients
    Lv, Meng
    Mao, Yan
    Song, Yuhua
    Wang, Yongmei
    Liu, Xiaoyi
    Wang, Xingang
    Nie, Gang
    Wang, Haibo
    [J]. CLINICAL BREAST CANCER, 2020, 20 (05) : E589 - E599
  • [10] A rapid rise in hormone receptor-positive and HER2-positive breast cancer subtypes in Southern Thai women: A population-based study in Songkhla
    Chuaychai, Aungkana
    Sriplung, Hutcha
    [J]. PLOS ONE, 2022, 17 (03):